[1]熊金娥,徐平明,付 琛.国产与进口甘精胰岛素制剂治疗糖尿病的临床效果及安全性比较[J].医学信息,2023,36(23):118-121.[doi:10.3969/j.issn.1006-1959.2023.23.030]
　XIONG Jin-e,XU Ping-ming,FU Chen.Comparison of Clinical Efficacy and Safety of Domestic and Imported Insulin Glargine in the Treatment of Diabetes Mellitus[J].Journal of Medical Information,2023,36(23):118-121.[doi:10.3969/j.issn.1006-1959.2023.23.030]
点击复制

国产与进口甘精胰岛素制剂治疗糖尿病的临床效果及安全性比较()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年23期
页码:
118-121
栏目:
药物与临床
出版日期:
2023-12-01

文章信息/Info

Title:
Comparison of Clinical Efficacy and Safety of Domestic and Imported Insulin Glargine in the Treatment of Diabetes Mellitus
文章编号:
1006-1959（2023）23-0118-04
作者:
熊金娥; 徐平明; 付 琛
（上高县人民医院药剂科，江西 上高 336400）
Author(s):
XIONG Jin-e; XU Ping-ming; FU Chen
(Department of Pharmacy,Shanggao County People’s Hospital,Shanggao 336400,Jiangxi,China)
关键词:
国产甘精胰岛素制剂; 进口甘精胰岛素制剂; 糖尿病
Keywords:
Domestic insulin glargine; Imported insulin glargine; Diabetes mellitus
分类号:
R977.15
DOI:
10.3969/j.issn.1006-1959.2023.23.030
文献标志码:
A
摘要:
目的 研究国产与进口甘精胰岛素制剂治疗糖尿病的临床效果及安全性。方法 选取2020年1月-2022年8月我院诊治的62例糖尿病患者为研究对象，采用随机数字表法分为对照组和观察组，各31例。对照组采用进口甘精胰岛素制剂治疗，观察组采用国产甘精胰岛素制剂治疗，比较两组临床效果、血糖指标[空腹血糖（FPG）、餐后2 h血糖（2 hPG）、糖化血红蛋白（HbA1c）]、血糖达标时间、胰岛素剂量、低血糖发生率、不良反应发生率以及经济成本。结果 观察组治疗总有效率为93.55%，低于对照组的96.77%，但差异无统计学意义（P＞0.05）；两组治疗后FPG、2 hPG、HbA1c水平均低于治疗前（P＜0.05），但组间比较，差异无统计学意义（P＞0.05）；观察组血糖达标时间与对照组比较，差异无统计学意义（P＞0.05），但观察组胰岛素剂量小于对照组（P＜0.05）；观察组低血糖发生率低于对照组，但差异无统计学意义（P＞0.05）；观察组不良反应发生率低于对照组（P＜0.05）；观察组用药物费用、治疗总费用均低于对照组（P＜0.05）。结论 国产甘精胰岛素制剂治疗糖尿病可实现与进口甘精胰岛素制剂相似的治疗效果，且国产甘精胰岛素制剂可改善血糖指标，减小胰岛素剂量，降低不良反应发生率，减少用药物费用和总治疗费用。
Abstract:
Objective To study the clinical effect and safety of domestic and imported insulin glargine in the treatment of diabetes mellitus.Methods A total of 62 diabetic mellitus patients diagnosed and treated in our hospital from January 2020 to August 2022 were selected as the research objects. They were divided into control group and observation group by random number table method, with 31 patients in each group. The control group was treated with imported insulin glargine, and the observation group was treated with domestic insulin glargine. The clinical effects, blood glucose indexes [fasting blood glucose (FPG), 2 h postprandial blood glucose (2 hPG), glycosylated hemoglobin (HbA1c)], blood glucose compliance time, insulin dose, incidence of hypoglycemia, incidence of adverse reactions and economic costs were compared between the two groups.Results The total effective rate of the observation group was 93.55%, which was lower than 96.77% of the control group, but the difference was not statistically significant (P>0.05). After treatment, the levels of FPG, 2 hPG and HbA1 c in the two groups were lower than those before treatment (P<0.05), but there was no significant difference in blood glucose index between the observation group and the control group (P>0.05). There was no significant difference in the time of blood glucose reaching the standard between the observation group and the control group (P>0.05), but the insulin dose in the observation group was lower than that in the control group (P<0.05). The incidence of adverse reactions in the observation group was lower than that in the control group (P<0.05). The drug cost and total cost of treatment in the observation group were lower than those in the control group (P<0.05).Conclusion Domestic insulin glargine can achieve similar therapeutic effect with imported insulin glargine in the treatment of diabetes mellitus, and domestic insulin glargine can improve blood glucose index, reduce insulin dose, reduce the incidence of adverse reactions, reduce drug costs and total treatment costs.

参考文献/References:

[1]赵茜,宋勇.甘精胰岛素联合二甲双胍治疗2型糖尿病患者临床疗效安全性及对糖代谢的影响研究[J].基层医学论坛,2018,22(8):1031-1032.[2]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1):4-67.[3]马咏梅.甘精胰岛素和门冬胰岛素30对2型糖尿病患者糖脂代谢影响的比较[J].医学综述,2016,22(22):4559-4561.[4]涂晶晶,唐建东,张维,等.达格列净联合甘精胰岛素及门冬胰岛素对2型糖尿病血糖控制不佳患者血糖波动的影响[J].中国老年学杂志,2020,40(10):2044-2047.[5]陆锦昆,潘琼华,潘海林,等.甘精胰岛素与门冬胰岛素30对2型糖尿病患者胰岛β细胞功能及血糖稳定性的影响[J].广西医科大学学报,2019,36(1):27-30.[6]高轩,胡倩,李洪林.阿卡波糖联合甘精胰岛素治疗2型糖尿病的临床效果及对患者氧化应激的影响[J].中国临床医生杂志,2020,48(4):424-426.[7]贺亚峰,郑皓,杨庚.甘精胰岛素联合瑞格列奈与双相门冬胰岛素治疗新诊断2型糖尿病的效果比较[J].贵州医药,2019,43(9):1412-1413.[8]Ma Q,Li Y,Li P,et al.Research progress in the relationship between type 2 diabetes mellitus and intestinal flora[J].Biomed Pharmacother,2019,117:109138.[9]楼时先,刘心雨,郑伟英.胰岛素强化治疗对初诊2型糖尿病患者血清炎症因子、氧化应激的影响观察[J].药物流行病学杂志,2019,28(12):792-795.[10]何建忠,陈光权.高通量血液透析对2型糖尿病肾病患者毒素清除和炎症因子、氧化应激因子水平的影响[J].标记免疫分析与临床,2019,26(4):571-575.[11]Pscherer S,Anderten H,Pfohl M,et al.Titration of insulin glargine 100 U/mL when added to oral antidiabetic drugs in patients with type 2 diabetes: results of the TOP-1 real-world study[J].Acta Diabetol,2020,57(1):89-99.[12]胡琛亮,奚宇,王玉婵,等.对新诊断2型糖尿病患者为期12周多次胰岛素类似物皮下注射强化治疗的疗效观察[J].中华全科医学,2019,17(10):1691-1693,1721.[13]韩旸,王凯亮,赖杰,等.不同胰岛素起始治疗方案对口服药失效的2型糖尿病患者β细胞功能的影响[J].贵州医药,2019,43(9):1391-1393.[14]杜宪,叶银梅,孙培环,等.老年2型糖尿病患者睡前误用门冬胰岛素致严重低血糖[J].药物不良反应杂志,2019,21(2):144-145.[15]黄建丽.国产重组甘精胰岛素注射液与来得时治疗糖尿病的效果和安全性比较[J].河南医学研究,2017,26(17):3156-3157.[16]胡广云,马向华.双时相门冬胰岛素联合二甲双胍对2型糖尿病患者的疗效和安全性研究[J].南京医科大学学报(自然科学版),2019,39(6):919-921.[17]索艳,刘冬梅,王肃.西格列汀二甲双胍联合甘精胰岛素治疗初发肥胖2型糖尿病的疗效与安全性[J].中国慢性病预防与控制,2019,27(11):852-855.[18]张俊岭,刘德宽.门冬胰岛素30与西格列汀治疗二甲双胍控制不佳2型糖尿病的效果比较[J].临床医学,2021,41(5):100-102.[19]郭亚慧.两种甘精胰岛素制剂对糖尿病患者疗效及安全性的系统评价[J].药品评价,2021,18(7):385-389.

更新日期/Last Update: 1900-01-01